We are live on ! Find out more
ALXN

Alexion Pharmaceuticals
ALXN

Delisted

ALXN was delisted on the 20th of July, 2021.

Back to rankings

824 hedge funds and large institutions have $31.3B invested in Alexion Pharmaceuticals in 2020 Q4 according to their latest regulatory filings, with 204 funds opening new positions, 241 increasing their positions, 284 reducing their positions, and 80 closing their positions.

New
Increased
Maintained
Reduced
Closed

156% more funds holding in top 10

Funds holding in top 10: 18 → 46 (+28)

155% more first-time investments, than exits

New positions opened: 204 | Existing positions closed: 80

38% more capital invested

Capital invested by funds: $22.6B → $31.3B (+$8.67B)

28% more call options, than puts

Call options by funds: $559M | Put options by funds: $436M

17% more funds holding

Funds holding: 707 → 824 (+117)

15% less repeat investments, than reductions

Existing positions increased: 241 | Existing positions reduced: 284

Holders
824
Holders Change
+117
Holders Change %
+16.55%
% of All Funds
14.58%
Holding in Top 10
46
Holding in Top 10 Change
+28
Holding in Top 10 Change %
+155.56%
% of All Funds
0.81%
New
204
Increased
241
Reduced
284
Closed
80
Calls
$559M
Puts
$436M
Net Calls
+$123M
Net Calls Change
+$163M

Top Buyers

1
PCM
Pentwater Capital Management
Florida
+$380M
2
FCM
Farallon Capital Management
California
+$289M
3
Adage Capital Partners
Adage Capital Partners
Massachusetts
+$271M
4
HI
HBK Investments
Texas
+$221M
5
Millennium Management
Millennium Management
New York
+$211M

Top Sellers

1
Fidelity Investments
Fidelity Investments
Massachusetts
-$451M
2
Ameriprise
Ameriprise
Minnesota
-$353M
3
O
OrbiMed
New York
-$259M
4
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
-$203M
5
AQR Capital Management
AQR Capital Management
Connecticut
-$194M
Name Holding Trade Value Shares
Change 		Change in
Stake
FPS
751
Fieldpoint Private Securities
Connecticut
$16K +$13.5K +105 New
EARNEST Partners
752
EARNEST Partners
Georgia
$15K – – –
AIG
753
American International Group
New York
$14.8K -$40K -311 -0.3%
WT
754
Washington Trust
Rhode Island
$14K -$1.03K -8 -8%
MHR
755
Matthew Hamilton Rosenberg
$14K – – –
EW
756
Evoke Wealth
California
$14K +$514 +4 +5%
PWMG
757
Prestige Wealth Management Group
New Jersey
$13K +$9.38K +73 +608%
CTFG
758
Capstone Triton Financial Group
Oklahoma
$12K +$9.64K +75 New
HIM
759
Hillsdale Investment Management
Ontario, Canada
$11K -$578K -4,500 -98%
AssetMark Inc
760
AssetMark Inc
California
$11K -$643 -5 -6%
M
761
MOTCO
Texas
$11K – – –
H
762
Hexavest
Quebec, Canada
$10K – – –
LWCFA
763
Loring Wolcott & Coolidge Fiduciary Advisors
Massachusetts
$10K – – –
NFSG
764
Newbridge Financial Services Group
Florida
$10K – – –
FGAM
765
Financial Gravity Asset Management
Texas
$10K +$8.48K +66 New
MTCM
766
Mint Tower Capital Management
Netherlands
$10K +$835K +6,500 New
TWA
767
TCI Wealth Advisors
Arizona
$9K +$386 +3 +6%
Jones Financial Companies
768
Jones Financial Companies
Missouri
$9K +$7.07K +55 New
SIAG
769
Safeguard Investment Advisory Group
California
$9K +$7.71K +60 New
VAIA
770
Virtus Alternative Investment Advisers
Connecticut
$8K -$6.17K -48 -49%
BC
771
Bartlett & Co
Ohio
$8K – – –
CAGAS
772
Capital Advisory Group Advisory Services
Minnesota
$8K – – –
TFO
773
Tarbox Family Office
California
$8K +$1.16K +9 +21%
CYG
774
Clean Yield Group
Vermont
$8K +$6.42K +50 New
BCWM
775
Bartlett & Co Wealth Management
Ohio
$7.81K – – –
29 30
31
32 33

ALXN Hedge Fund Activity: Q4 2020 in Review

824 of the 5,651 institutional investors tracked by Wall St. Rank reported a position in Alexion Pharmaceuticals (ALXN) for Q4 2020, worth a combined $31.3B — up 38% from $22.6B a quarter earlier.

Buyers outnumbered sellers: 204 funds opened new ALXN positions and 80 closed out — a net gain of 124 holders — while 241 added to existing stakes and 284 trimmed.

The largest buyer was Pentwater Capital Management, opening a new position worth an estimated $380M. The largest seller was Fidelity Investments, cutting an estimated $451M.

  • 824 institutional investors held Alexion Pharmaceuticals (ALXN) as of Q4 2020, up from 707 in Q3 2020.
  • Funds reported $31.3B of Alexion Pharmaceuticals stock for Q4 2020, up 38% quarter-over-quarter.
  • 204 funds opened new Alexion Pharmaceuticals positions in Q4 2020 and 80 closed out, a net change of +124 holders.
  • The largest Alexion Pharmaceuticals buyer in Q4 2020 was Pentwater Capital Management, an estimated $380M added.
  • The largest Alexion Pharmaceuticals seller in Q4 2020 was Fidelity Investments, an estimated $451M sold.

Based on aggregated 13F filings for Q4 2020.